Tumor-associated macrophage (TAM)-secreted CCL22 confers cisplatin resistance of esophageal squamous cell carcinoma (ESCC) cells via regulating the activity of diacylglycerol kinase α (DGKα)/NOX4 axis
Jie Chen, Di Zhao, Lingyuan Zhang, Jing Zhang, Yuanfan Xiao, Qingnan Wu, Yan Wang, Qimin Zhan
Topics & Concepts
Cancer researchCisplatinChemistryCCL22Tumor progressionBiologyChemokineChemokine receptorInternal medicineMedicineBiochemistryReceptorChemotherapyGeneImmune cells in cancerChemokine receptors and signalingSphingolipid Metabolism and Signaling